drugset / Trial / NCT06168812
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Phase 2
Active not recruiting
29 enrolled
Memorial Sloan Kettering Cancer Center
University of California, Berkeley · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.
Timeline
- Start
- 2023-12-05
- Primary completion
- 2026-12-05
- Completion
- 2026-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glipizide | Small molecule | — | — |